Understanding your Maternal Fetal Medicine Associates, Carnegie Imaging for Women, Carnegie South Imaging for Women, and Carnegie Women’s Health (collectively, “MFMA”) data breach notification letter

Why you received this letter

Maternal Fetal Medicine Associates, Carnegie Imaging for Women, Carnegie South Imaging for Women, and Carnegie Women’s Health (collectively, "MFMA") operate at the highly specialized intersection of maternal-fetal medicine, advanced obstetric and gynecological imaging, and comprehensive women's healthcare. Because of the critical nature of their clinical operations, these affiliated practices routinely collect and maintain vast repositories of extraordinarily sensitive patient files. This includes comprehensive obstetrical histories, complex fetal ultrasound and imaging records, detailed diagnostic evaluations, genetic screening results, and personal demographic information. The intimate and specialized nature of the medical care provided means that patients trust MFMA with some of the most private, vulnerable aspects of their personal lives and health histories, necessitating a corresponding duty of absolute data security. In 2025, MFMA reported a significant security incident to the Massachusetts Attorney General, bringing to light a breach that compromises the digital defenses safeguarding this sensitive repository of patient information. While investigations into healthcare sector cyberattacks typically point toward sophisticated network intrusions, unauthorized system access, or vulnerabilities introduced via third-party digital vendors and cloud-hosted medical databases, the reality of such a breach underscores the profound risks associated with digitized medical records. Healthcare providers remain prime targets for malicious cybercriminals due to the immense black-market value of medical data, which can be leveraged for various fraudulent schemes long after a network perimeter has been breached. The exposure of protected health information and personally identifiable information in this breach creates immediate, multi-faceted risks for every affected patient. Compromised data fields typically encompass full names, dates of birth, Social Security numbers, medical record numbers, health insurance details, and highly sensitive clinical diagnosis and treatment notes. Unlike a stolen credit card, a compromised medical record or Social Security number cannot simply be cancelled and reissued. This data exposes victims to severe, long-term threats of medical identity theft—where unauthorized actors obtain treatment under a victim's name, corrupting their official medical history—as well as financial fraud, tax refund scams, and targeted phishing attacks utilizing specific details about their healthcare providers and medical conditions. Under federal and state law, healthcare entities like MFMA are bound by strict legal mandates to secure patient data against unauthorized access and disclosure. The Health Insurance Portability and Accountability Act (HIPAA), alongside Massachusetts data privacy statutes, requires covered entities and their business associates to implement robust administrative, physical, and technical safeguards. These obligations include conducting regular security risk assessments, maintaining encrypted databases, enforcing strict access controls, and swiftly patching known system vulnerabilities. A data breach of this magnitude serves as a strong indicator that these critical legal safeguards may have failed, raising serious questions about whether institutional security protocols met the required standard of care. Receiving a formal data breach notification letter from MFMA is a serious legal development; it serves as an official admission by the healthcare provider that your confidential information was compromised while under their direct care and control. Legally, the receipt of this letter establishes the foundational standing required to participate in a class action lawsuit aimed at holding the organization accountable for its security failures. Crucially, affected individuals do not need to demonstrate that they have already suffered actual financial loss or identity theft to pursue legal remedies; the increased, imminent risk of future harm is sufficient under the law. Our firm is actively investigating potential class action claims on behalf of patients whose data was exposed, operating strictly on a contingency fee basis—meaning you pay nothing out of pocket, and there are no fees unless we successfully recover compensation for you.